ISCA Archive Larynx 1997
ISCA Archive Larynx 1997

Tracheo-esophageal voice after laryngectomy (BIOMED 1- BMT concerted action 94-1611)

H. F. Mahieu, J. Algaba, A. D. Cheesman, A. S. Dagli, D. Dehesdin, M. Remacle, N. Santiago Silva, H. K. Schutte, I. F. Herrmann, A. Staffieri, L. Traissac, A. Parker, C. A. Meeuwis

Laryngeal and pharyngeal cancers are by far the most frequent occuring cancers in the upper airway and digestive tract. Reported incidences in Europe vary between 11.4 per 100.000 inhabitants (Spain, Italy) and less than half that number in Denmark and the Netherlands. Between 5 to 20% of these cancers will require treatment with total laryngectomy, depending upon etiological background (e.g. smoking and drinking) and treatment protocols (e.g. radiotherapy vs surgery).


Cite as: Mahieu, H.F., Algaba, J., Cheesman, A.D., Dagli, A.S., Dehesdin, D., Remacle, M., Silva, N.S., Schutte, H.K., Herrmann, I.F., Staffieri, A., Traissac, L., Parker, A., Meeuwis, C.A. (1997) Tracheo-esophageal voice after laryngectomy (BIOMED 1- BMT concerted action 94-1611). Proc. LARYNX 1997, 99-104

@inproceedings{mahieu97_larynx,
  author={H. F. Mahieu and J. Algaba and A. D. Cheesman and A. S. Dagli and D. Dehesdin and M. Remacle and N. Santiago Silva and H. K. Schutte and I. F. Herrmann and A. Staffieri and L. Traissac and A. Parker and C. A. Meeuwis},
  title={{Tracheo-esophageal voice after laryngectomy (BIOMED 1- BMT concerted action 94-1611)}},
  year=1997,
  booktitle={Proc. LARYNX 1997},
  pages={99--104}
}